MeVis Medical Solutions AG
Research MeVis Medical Solutions AG (M3V) on Bullrun: market cap EUR 44.04M, P/E 57.6, dividend yield 4.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerM3V
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyEUR
- Market capEUR 44.04M
- P/E57.6
- Dividend yield4.0%
- Financial periodFY2025
- RevenueEUR 16.06M
- Revenue growth-5.4%
- Net incomeEUR 3.17M
- Free cash flowEUR 3.74M
- Gross margin97.7%
Valuation Snapshot
latest market cap is EUR 44.04M; P/E is 57.6; dividend yield is 4.0%.
About MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases.
Frequently asked questions
What is MeVis Medical Solutions AG's market cap?
MeVis Medical Solutions AG's market capitalization is EUR 44.04M.
What is MeVis Medical Solutions AG's P/E ratio?
MeVis Medical Solutions AG's price-to-earnings (P/E) ratio is 57.6.
Does MeVis Medical Solutions AG pay a dividend?
MeVis Medical Solutions AG has a dividend yield of 4.0%.
What does MeVis Medical Solutions AG do?
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe.